Submitted by Anonymous (not verified) on 10 September 2025 - 13:47
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 12, Status: Authorised